(Q41211903)

28 September 2017

Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients (English)

1 reference

28 September 2017

1 reference

Palomares MR

1

1 reference

28 September 2017

Sayre JW

2

1 reference

28 September 2017

Shekar KC

3

1 reference

28 September 2017

Lillington LM

4

1 reference

28 September 2017

Chlebowski RT

5

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

28 September 2017

1 reference

28 September 2017

78

1 reference

28 September 2017

10

1 reference

28 September 2017

2119-2126

1 reference

28 September 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Chemotherapy of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Why do patients with emphysema lose weight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Gonadal endocrine dysfunction in patients with lung cancer: relation to responsiveness to chemotherapy, respiratory function and performance status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Sex-associated differences in presentation and survival in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

The cancer anorexia-cachexia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Serum androgens and gonadotrophins in bronchial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Transdermal testosterone substitution therapy for male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961115%2978%3A10%3C2119%3A%3AAID-CNCR12%3E3.0.CO%3B2-1

10.1002/(SICI)1097-0142(19961115)78:10<2119::AID-CNCR12>3.0.CO;2-1

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference